Ginkgo Bioworks Holdings Inc Class (DNA)
Stock-Based Compensation
$7.60M
Quarterly · Period ending: · USD
DNA Stock-Based Compensation
Latest reported$7.60Mperiod ending
Latest reported$7.60Mperiod ending
DNA Quarterly Stock-Based Comp ($123.00K → $7.60M)
Quarterly stock-based compensation
High-resolution chart · PNG
DNA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 7,595,000 | |
| 15,853,000 | |
| 21,027,000 | |
| 17,841,000 | |
| 22,247,000 | |
| 20,431,000 | |
| 20,561,000 | |
| 0 | |
| 37,146,000 | |
| 40,782,000 | |
| 0 | |
| 52,573,000 | |
| 0 | |
| 0 | |
| 118,448,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 127,000 | |
| 0 | |
| 0 | |
| 118,000 | |
| 118,000 | |
| 117,000 | |
| 123,000 |